Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
					Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





n-Pentane																				Related Pages
										May 1994
Immediately Dangerous to Life or Health Concentrations (IDLH)
**CAS number:** 109–66–0
**NIOSH REL:** 120 ppm (350 mg/m3) TWA,
610 ppm (1,800 mg/m3) 15-minute CEILING
**Current OSHA PEL:** 1,000 ppm (2,950 mg/m3) TWA
**1989 OSHA PEL:** 600 ppm (1,800 mg/m3) TWA, 750 ppm (2,250 mg/m3) STEL
**1993-1994 ACGIH TLV:** 600 ppm (1,770 mg/m3) TWA, 750 ppm (2,210 mg/m3) STEL
**Description of substance:** Colorless liquid with a gasoline-like odor.
**LEL** :. . 1.5% (10% LEL, 1,500 ppm)
**Original (SCP) IDLH:** 15,000 ppm [LEL]
**Basis for original (SCP) IDLH:** Patty [1963] reported the following: “n-pentane causes narcosis in 5 to 60 minutes at 90,000 to 120,000 ppm. Only a narrow margin exists between the concentrations that cause narcosis and death in mice. In human studies, a 10-minute exposure to 5,000 ppm did not cause mucous membrane irritation or other symptoms. The odor of n-pentane at this concentration is readily detectable” [Fuhner 1921]. AIHA [1966] reported that the atmospheric concentration immediately hazardous to life is unknown for man, but that the lethal concentration for mice has been reported as 128,200 ppm for a 37-minute exposure [Spector 1956]. Because the data indicate that acute toxic effects occur above the lower explosive limit (LEL) of 15,000 ppm, the LEL has been chosen as the IDLH (i.e., the concentration above which only the “most protective” respirators are permitted).
**Short-term exposure guidelines:** None developed
**ACUTE TOXICITY DATA:**
**Lethal concentration data:**

**Species**
    **Reference**
    **LC50**
    **LCLo**
    **Time**
    **Adjusted 0.5-hr** **LC (CF)**
    **Derived value**Mouse
    Flury & Zernik 1931
    -----
    130,000 mg/m3
    30 min
    130,000 ppm (1.0)
    13,000 ppmMouse
    Spector 1956
    -----
    128,200 ppm
    37 min
    137,175 ppm (1.07)
    13,718 ppmMouse
    Stoughton & Lamson 1936
    -----
    325,000 mg/m3
    2 hr
    173,333 ppm (1.6)
    17,333 ppm**Other animal data:** It has been reported that narcosis occurs after 5 to 60 minutes of exposure to 90,000 to 120,000 ppm [Patty 1963].
 **Human data:** Mucous membrane irritation or other symptoms were not noted after a 10-minute exposure of 5,000 ppm [Patty and Yant 1929].
 
 **Revised IDLH:** 1,500 ppm [LEL] **Basis for revised IDLH:** Based on health considerations and acute inhalation toxicity data in humans [Patty and Yant 1929], a value of at least 5,000 ppm would have been appropriate for n-pentane. However, the revised IDLH for n-pentane is 1,500 ppm based strictly on safety considerations (i.e., being 10% of the lower explosive limit of 1.5%).**REFERENCES:**
1. AIHA [1966]. Pentane (n-pentane). In: Hygienic guide series. Am Ind Hyg Assoc J *27*:207-209.
2. Flury F, Zernik F [1931]. Schädliche gase dämpfe, nebel, rauch- und staubarten. Berlin, Germany: Verlag von Julius Springer, pp. 257-284 (in German).
3. Fuhner H [1921]. The narcotic effect of gasoline and its components: pentane, hexane, heptane, octane. Biochemische Zeitschrift *115*:235-261 (translated).
4. Patty FA, ed. [1963]. Industrial hygiene and toxicology. 2nd rev. ed. Vol. II. Toxicology. New York, NY: Interscience Publishers, Inc., p. 1198.
5. Patty FA, Yant WP [1929]. Odor intensity and symptoms produced by commercial propane, butane, pentane, hexane, and heptane vapor. Pittsburgh, PA: Department of Commerce, U.S. Bureau of Mines, Report of Investigations, No. 2979, pp. 1-10.
6. Spector WS, ed. [1956]. Handbook of toxicology. Vol. I. Acute toxicities. Philadelphia, PA: W.B. Saunders Company, pp. 346-347.
7. Stoughton RW, Lamson PD [1936]. The relative anaesthetic activity of the butanes and pentanes. J Pharmacol Exp Ther *58*:74-77.

			
							
								Page last reviewed:  December 4, 2014						Content
							source: 	National Institute for Occupational Safety and Health NIOSH Publications & Products
Immediately Dangerous To Life or Health (IDLH) Values
Table of IDLH Values
Criteria for Determining IDLH Values
Historical Documentation
Original (SCP) Values
Abbreviations for IDLH Documentation
Abbreviations for Journal Titles Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification/Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
					Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
					You will be subject to the destination website's privacy policy when you follow the link.
					CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue